$4.67▴ 1.30%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
0.0%year over year
Watch
Revenue growth has flattened.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
✦ The read
Silo Pharma, Inc.'s earnings-quality signal is not available yet. Revenue growth has flattened.
Key numbers
Recent news
Sentiment · last 30 days3 articles
2 bullish1 neutral0 bearish
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform
Signals and key numbers are from the fiscal Q1 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.